Christopher Boerner
Chief Commercialization Officer
Other
CEO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Bristol Myers Squibb Co (BMY) | Board Chair and Chief Executive Officer | $1,586,346 | $21,879,919 |
| 2024 | Bristol Myers Squibb Co (BMY) | Board Chair and Chief Executive Officer | $1,536,538 | $18,787,618 |
| 2023 | Bristol Myers Squibb Co (BMY) | Board Chair and Chief Executive Officer | $1,256,921 | $8,461,833 |
| 2022 | Bristol Myers Squibb Co (BMY) | Board Chair and Chief Executive Officer | $1,064,049 | $6,880,220 |
Earnings-call appearances
-
Bristol Myers Squibb Co Q3 FY2025 Earnings Call2025-10-30
Bristol Myers Squibb Co (BMY)
-
Bristol Myers Squibb Co Q2 FY2025 Earnings Call2025-07-31
Bristol Myers Squibb Co (BMY)
-
Bristol Myers Squibb Co Q1 FY2025 Earnings Call2025-04-24
Bristol Myers Squibb Co (BMY)
-
Bristol Myers Squibb Co Q4 FY2024 Earnings Call2025-02-06
Bristol Myers Squibb Co (BMY)
-
Bristol Myers Squibb Co Q1 FY2024 Earnings Call2024-04-25
Bristol Myers Squibb Co (BMY)
-
Bristol Myers Squibb Co Q2 FY2023 Earnings Call2023-07-27
Bristol Myers Squibb Co (BMY)
-
Bristol Myers Squibb Co Q1 FY2023 Earnings Call2023-04-27
Bristol Myers Squibb Co (BMY)
-
Bristol Myers Squibb Co Q4 FY2022 Earnings Call2023-02-02
Bristol Myers Squibb Co (BMY)
-
Bristol Myers Squibb Co Q3 FY2022 Earnings Call2022-10-26
Bristol Myers Squibb Co (BMY)
-
Bristol Myers Squibb Co Q4 FY2021 Earnings Call2022-02-04
Bristol Myers Squibb Co (BMY)
-
Bristol Myers Squibb Co Q4 FY2020 Earnings Call2021-02-04
Bristol Myers Squibb Co (BMY)